SFM
KURA icon

Sphera Funds Management’s Kura Oncology KURA Stock Holding History

Sphera Funds Management’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.24M Sell
295,039
-483
-0.2% -$4.56K 0.42% 78
2026
Q1 		$2.4M Hold
295,522
– – 0.38% 74
2025
Q4 		$3.07M Buy
295,522
+50,000
+20% +$525K 0.59% 62
2025
Q3 		$2.17M Buy
245,522
+10,000
+4% +$71.3K 0.46% 69
2025
Q2 		$1.36M Sell
235,522
-108,000
-31% -$662K 0.32% 78
2025
Q1 		$2.27M Sell
343,522
-266,565
-44% -$2.08M 0.52% 61
2024
Q4 		$5.31M Hold
610,087
– – 0.96% 39
2024
Q3 		$11.9M Sell
610,087
-739
-0.1% -$15K 1.9% 13
2024
Q2 		$12.6M Hold
610,826
– – 1.72% 15
2024
Q1 		$13M Sell
610,826
-92,461
-13% -$1.8M 1.83% 13
2023
Q4 		$10.1M Hold
703,287
– – 1.63% 19
2023
Q3 		$6.41M Buy
703,287
+100,000
+17% +$1.02M 1.17% 28
2023
Q2 		$6.38M Hold
603,287
– – 1% 36
2023
Q1 		$7.38M Buy
603,287
+45,000
+8% +$562K 1.23% 25
2022
Q4 		$6.93M Sell
558,287
-231,665
-29% -$3.37M 1.49% 22
2022
Q3 		$10.8M Buy
789,952
+295,357
+60% +$4.56M 1.5% 15
2022
Q2 		$9.07M Sell
494,595
-123,649
-20% -$1.78M 0.97% 23
2022
Q1 		$9.94M Sell
618,244
-213,994
-26% -$3.09M 1.41% 22
2021
Q4 		$11.7M Buy
832,238
+43,503
+6% +$705K 1.28% 25
2021
Q3 		$14.8M Sell
788,735
-80,151
-9% -$1.51M 1.24% 17
2021
Q2 		$18.1M Buy
868,886
+151,135
+21% +$3.75M 1.23% 23
2021
Q1 		$20.3M Buy
717,751
+246,257
+52% +$7.79M 1.56% 13
2020
Q4 		$15.4M Buy
471,494
+112,000
+31% +$3.94M 1.37% 16
2020
Q3 		$11M Sell
359,494
-175,000
-33% -$3.86M 1.08% 24
2020
Q2 		$8.71M Buy
+534,494
New +$7.71M 0.82% 33
2018
Q3 		– Sell
-351,953
Closed -$6.41M – 118
2018
Q2 		$6.41M Buy
351,953
+21,953
+7% +$372K 0.88% 28
2018
Q1 		$6.19M Buy
+330,000
New +$6.42M 0.94% 33

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Sphera Funds Management's KURA Position: Q2 2026 in Review

Sphera Funds Management reduced its Kura Oncology (KURA) stake by 0.16% in Q2 2026, selling an estimated $4.56K and leaving 295,039 shares worth $3.24M. The position accounts for 0.42% of the portfolio, ranked #78.

Sphera Funds Management first reported a position in KURA in Q1 2018 and has held it in 27 quarters since. The position peaked at $20.3M in Q1 2021. 220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Sphera Funds Management held 295,039 shares of Kura Oncology worth $3.24M as of Q2 2026.
  • Sphera Funds Management sold 483 Kura Oncology shares in Q2 2026, an estimated $4.56K.
  • Kura Oncology made up 0.42% of Sphera Funds Management's portfolio in Q2 2026, its #78 holding.
  • Sphera Funds Management first reported a position in Kura Oncology in Q1 2018 and has held it in 27 quarters since.
  • Sphera Funds Management's Kura Oncology position peaked at $20.3M in Q1 2021.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Sphera Funds Management's 13F filing for Q2 2026, filed 14 Aug 2026.